Ganga Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹13.32(0.00%)May 23, 2025 16:00:02 PM IST
- NSE
- BSE
- Vol : 0 (NSE + BSE)Last 20 day avg : 0
Ganga Pharmaceuticals is trading 0.00% upper at Rs 13.32 as compared to its last closing price. Ganga Pharmaceuticals has been trading in the price range of 0.00 & 0.00. Ganga Pharmaceuticals has given -28.46% in this year & 0.00% in the last 5 days. Ganga Pharmaceuticals has TTM P/E ratio 63.56 as compared to the sector P/E of 44.49.The company posted a net profit of 0.06 Crores in its last quarter.Listed peers of Ganga Pharmaceuticals include Shamrock Industrial (-%), Vivanza Biosciences (2.87%), Ganga Pharmaceuticals (-%).The Mutual Fund holding in Ganga Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Ganga Pharmaceuticals was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Jun 22, 2025, 02:02 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/B0.90The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values111.00Price-to-earnings ratio based on trailing 12-month earnings
- Debt To EquityHigher than industry0.20The debt-to-equity ratio, indicating a company's financial leverage.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable
The debt to equity of the company is higher than the industry median- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- -
- R2
- -
- R3
- -
- S1
- -
- S2
- -
- S3
- -
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Shamrock Industrial | Bullish | 15.98 | - | 8.67 | - | 5.41 | - | - |
| Vivanza Biosciences | Bearish | 2.15 | 2.87 | 8.64 | - | 2.14 | - | 84.13 |
| Ganga Pharmaceuticals | Moderately Bearish | 13.32 | - | 6.44 | 111.00 | 0.9 | - | 3.25 |
| Kobo Biotech | Bearish | 2.45 | -2.78 | 5.83 | - | - | - | |
| Brawn Biotech | Neutral | 17.02 | 5.00 | 5.10 | - | 1.52 | - | - |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-20 | Audited Results |
| 2024-11-08 | Half Yearly Results |
| 2024-05-16 | Audited Results |
| 2023-12-04 | Preferential issue of shares |
| 2023-11-08 | Half Yearly Results |
- IndustryBiotechnology & Drugs
- ISININE615T01017
- BSE Code539680
- NSE Code
Ganga Pharmaceuticals is trading at 13.32 as on Fri May 23 2025 10:30:02. This is 0.00% upper as compared to its previous closing price of 13.32.
The market capitalization of Ganga Pharmaceuticals is 6.44 Cr as on Fri May 23 2025 10:30:02.
The 52 wk high for Ganga Pharmaceuticals is 27.10 whereas the 52 wk low is 9.25
Ganga Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 63.56
- Sector P/E: 44.49
- Dividend Yield: 0.00%
- D/E ratio: 0.20
Ganga Pharmaceuticals reported a net profit of 0.08 Cr in 2025.